Autonomic ganglionic nicotinic acetylcholine receptor (Nn)

The autonomic ganglionic nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel located on the postsynaptic membranes of neurons within the sympathetic and parasympathetic ganglia, as well as the adrenal medulla (StatPearls, 2023). It primarily consists of alpha-3 (CHRNA3) and beta-4 (CHRNB4) subunits, which distinguishes it from the neuromuscular (alpha-1) and central nervous system (alpha-4/beta-2 or alpha-7) subtypes (UniProt, 2024). Upon binding of the neurotransmitter acetylcholine, the receptor undergoes a conformational change that allows the influx of cations, primarily sodium and calcium, leading to depolarization and the propagation of action potentials across the autonomic synapse (PubMed, 2022). This receptor plays a critical role in regulating involuntary physiological processes, including heart rate, blood pressure, and gastrointestinal motility (NIH, 2023). Historically, ganglionic blockers like hexamethonium and trimetaphan were used to treat hypertension, but their use is now limited due to extensive side effects resulting from non-selective autonomic inhibition. Today, the receptor is a key target in diagnosing autoimmune autonomic ganglionopathy, a condition where autoantibodies against the alpha-3 subunit impair ganglionic transmission (Journal of Clinical Neurology, 2020).

Other names

Ganglionic nicotinic receptorNeuronal nicotinic acetylcholine receptor alpha-3 beta-4Peripheral neuronal nicotinic acetylcholine receptorGanglion-type nicotinic receptor

Agonism (activation of the ion channel leading to depolarization) and Antagonism (competitive or non-competitive blockade of the channel to inhibit ganglionic transmission).